As of 2025-07-02, the EV/EBITDA ratio of Novocure Ltd (NVCR) is -16.52. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. Novocure's latest enterprise value is 2,524.48 mil USD. Novocure's TTM EBITDA according to its financial statements is -152.82 mil USD. Dividing these 2 quantities gives us the above Novocure EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 7.9x - 13.6x | 9.5x |
| Forward P/E multiples | 18.5x - 24.2x | 21.2x |
| Fair Price | (30.18) - (23.41) | (25.77) |
| Upside | -268.8% - -230.9% | -244.1% |
| Date | EV/EBITDA |
| 2025-07-01 | -16.52 |
| 2025-06-30 | -16.46 |
| 2025-06-27 | -16.61 |
| 2025-06-26 | -15.95 |
| 2025-06-25 | -16.11 |
| 2025-06-24 | -15.88 |
| 2025-06-23 | -15.59 |
| 2025-06-20 | -15.65 |
| 2025-06-18 | -15.73 |
| 2025-06-17 | -16.19 |
| 2025-06-16 | -16.54 |
| 2025-06-13 | -16.28 |
| 2025-06-12 | -16.75 |
| 2025-06-11 | -16.14 |
| 2025-06-10 | -16.88 |
| 2025-06-09 | -15.80 |
| 2025-06-06 | -15.88 |
| 2025-06-05 | -15.48 |
| 2025-06-04 | -15.67 |
| 2025-06-03 | -15.91 |
| 2025-06-02 | -15.91 |
| 2025-05-30 | -17.42 |
| 2025-05-29 | -17.63 |
| 2025-05-28 | -17.61 |
| 2025-05-27 | -17.47 |
| 2025-05-23 | -17.00 |
| 2025-05-22 | -16.69 |
| 2025-05-21 | -16.42 |
| 2025-05-20 | -16.75 |
| 2025-05-19 | -16.58 |
| 2025-05-16 | -16.53 |
| 2025-05-15 | -16.31 |
| 2025-05-14 | -15.95 |
| 2025-05-13 | -16.71 |
| 2025-05-12 | -17.02 |
| 2025-05-09 | -16.15 |
| 2025-05-08 | -16.20 |
| 2025-05-07 | -15.62 |
| 2025-05-06 | -15.39 |
| 2025-05-05 | -16.43 |
| 2025-05-02 | -16.72 |
| 2025-05-01 | -16.57 |
| 2025-04-30 | -16.71 |
| 2025-04-29 | -16.82 |
| 2025-04-28 | -16.83 |
| 2025-04-25 | -16.97 |
| 2025-04-24 | -17.01 |
| 2025-04-23 | -16.44 |
| 2025-04-22 | -15.52 |
| 2025-04-21 | -14.84 |